LIPOCINE INC. Proceeds from Issuance of Debt
LIPOCINE INC. (LPCN) reported Proceeds from Issuance of Debt of $233.54 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2022-03-09
- LIPOCINE INC. proceeds from issuance of debt for the quarter ending 2020-12-31 was $0.00.
- LIPOCINE INC. proceeds from issuance of debt for the quarter ending 2020-09-30 was $0.00.
- LIPOCINE INC. proceeds from issuance of debt for the quarter ending 2019-12-31 was $0.00.
- LIPOCINE INC. proceeds from issuance of debt for the quarter ending 2019-09-30 was $0.00.
- LIPOCINE INC. proceeds from issuance of debt for fiscal 2020 was $233.54K.
- LIPOCINE INC. proceeds from issuance of debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- LIPOCINE INC. proceeds from issuance of debt for fiscal 2018 was $10.00M.
- LIPOCINE INC. proceeds from issuance of debt for fiscal 2017 was $0.00.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $0.00 derived: sum of 2 quarters · filed 2022-03-09 | $233.54K 10-K · filed 2022-03-09 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $233.54K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $233.54K 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 10-K · filed 2021-03-11 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $0.00 derived: sum of 3 quarters · filed 2020-03-13 | $10.00M 10-K · filed 2020-03-13 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $10.00M 10-Q · filed 2019-11-12 | $10.00M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $10.00M 10-Q · filed 2019-08-07 | $10.00M derived: sum of 3 quarters · filed 2019-08-07 | $10.00M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $10.00M 10-Q · filed 2019-05-08 | $10.00M derived: sum of 2 quarters · filed 2019-05-08 | $10.00M derived: sum of 3 quarters · filed 2019-05-08 | $10.00M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-07 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |